Cardiometabolic Health Congress Expert Faculty Evaluate the Clinical…

The U.S. Food and Drug Administration (FDA) approved JUXTAPID™ (lomitapide), a new, first-in-class treatment option for clinical management of patients with homozygous familial hypercholesterolemia…

(PRWeb January 08, 2013)

Read the full story at

Click here for reuse options!
Copyright 2013 Biotechblog

Comments are closed.

%d bloggers like this: